−0.0887USD
−472.74 KUSD
119.34 KUSD
5.05 M
About CYduct Diagnostics Inc.
Sector
Industry
CEO
Dominick L. Gatto
Website
Headquarters
Westport
Founded
1986
FIGI
BBG000GQM3P6
CYduct Diagnostics, Inc. engages in the development and marketing of technology, applications, medical devices, and procedural techniques for screening, diagnosis, treatment, and management of disease and medical conditions. Its products include Laparoscopic Instruments, MammoView, Endoscopes, Endocouplers, and Trocars & Cannulas. The company was founded on April 16, 1986 and is headquartered in Westport, CT.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CYDX is 0.3000 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange CYduct Diagnostics Inc. stocks are traded under the ticker CYDX.
CYDX stock is 0% volatile and has beta coefficient of 0.14. Check out the list of the most volatile stocks — is CYduct Diagnostics Inc. there?
Yes, you can track CYduct Diagnostics Inc. financials in yearly and quarterly reports right on TradingView.
CYDX net income for the last quarter is −105.52 K USD, while the quarter before that showed −102.37 K USD of net income which accounts for −3.08% change. Track more CYduct Diagnostics Inc. financial stats to get the full picture.
No, CYDX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYDX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYduct Diagnostics Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CYduct Diagnostics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CYduct Diagnostics Inc. stock shows the sell signal. See more of CYduct Diagnostics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CYduct Diagnostics Inc. EBITDA is −423.14 K USD, and current EBITDA margin is −369.75%. See more stats in CYduct Diagnostics Inc. financial statements.